Search alternatives:
significant adverse » significant advantage (Expand Search), significant decrease (Expand Search)
adverse decrease » rivers decreased (Expand Search)
role decrease » rate decreased (Expand Search), road decreased (Expand Search), note decreased (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search), fold increases (Expand Search)
Showing 1 - 20 results of 5,634 for search '(( significant adverse decrease ) OR ( significant ((role decrease) OR (fold decrease)) ))', query time: 0.41s Refine Results
  1. 1
    Adverse cardiovascular events by immune checkpoint inhibitor.

    Adverse cardiovascular events by immune checkpoint inhibitor. by Jennifer M. Kwan (3350321)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 2
    Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events.

    Baseline demographics and comorbidities by presence of post-treatment adverse cardiovascular events. by Jennifer M. Kwan (3350321)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 3
    Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in oxidative stress levels.

    Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in oxidative stress levels. by Qi He (384033)

    Published 2025
    Save to List
    Saved in:
  4. 4
    Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in lipid peroxidation levels.

    Mice subjected to chronic stress and provided with HRW exhibited a significant reduction in lipid peroxidation levels. by Qi He (384033)

    Published 2025
    Save to List
    Saved in:
  5. 5
    MiR-129-5p levels were decreased in mouse depression models.

    MiR-129-5p levels were decreased in mouse depression models. by Qiaozhen Qin (13159201)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 6
    Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE.

    Cox regression models for adverse cardiovascular events (ACE) and individual components of ACE. by Jennifer M. Kwan (3350321)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 7
    Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells.

    Arctigenin decreased proliferation in colorectal cancer cells with no significant effect on normal cells. by Xiang-Fan Chen (13932983)

    Published 2024
    Save to List
    Saved in:
  8. 8
    IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1.

    IRE1 depletion decreases heterochromatin, DNA and H3K9me3 methylation, and UHRF1. by Iratxe Zuazo-Gaztelu (21071939)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 9
    Screening for gHgLgO interaction partners reveals decreased binding of the gO249 mutant to cell surfaces.

    Screening for gHgLgO interaction partners reveals decreased binding of the gO249 mutant to cell surfaces. by Lena Thiessen (17605194)

    Published 2025
    Save to List
    Saved in:
  10. 10
    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures.

    The binding energy values of ATP, ALK inhibitors and ABT-199 to ALK were obtained from AlphaFold and modeled protein structures. by Richard Junior Zapata Dongo (17912565)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 11
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 12
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 13
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 14
    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations

    6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 15
    Degeneration Saline group presented with significant decreased final weight in relation to other groups.

    Degeneration Saline group presented with significant decreased final weight in relation to other groups. by Flavia Gomes Velasque Gama (21175112)

    Published 2025
    Save to List
    Saved in:
  16. 16
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 <sup>a</sup> indicates ≥1.50 SD (17.9) from the mean (32.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2018 <sup>a</sup> indicates ≥1.50 SD (17.9) from the mean (32.9... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 17
    Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 <sup>a</sup> indicates ≥1.50 SD (20.2) from the mean (36.4), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (11.1-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2015 <sup>a</sup> indicates ≥1.50 SD (20.2) from the mean (36.... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 18
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 <sup>a</sup> indicates ≥1.50 SD (18.0) from the mean (33.1), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2017 <sup>a</sup> indicates ≥1.50 SD (18.0) from the mean (33.1... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 19
    Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 <sup>a</sup> indicates ≥1.50 SD (16.8) from the mean (31.0), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.5-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2019 <sup>a</sup> indicates ≥1.50 SD (16.8) from the mean (31.0... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 20
    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9), which is denoted by the dotted line. <sup>b</sup> indicates ≥1.96 SD from the mean.

    Large state-wide variation (8.6-fold) in number of clozapine prescriptions per thousand Medicare Part D enrollees in 2020 <sup>a</sup> indicates ≥1.50 SD (16.0) from the mean (29.9... by Luke R. Cavanah (19022435)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: